Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-253459

Chief Executive Officer sold 12,837 shares at $69.74 ($895,252)

  • Chief Executive Officer gave 300,000 shares (gift)
  • Chief Executive Officer gave 300,000 shares (gift)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BELANOFF JOSEPH K · Chief Executive Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-05-29 Gift : show line 1 in the form 10b5-1 −300,000 2,578,326 I
2026-05-29 Gift : show line 2 in the form 10b5-1 +150,000 150,000 I
2026-05-29 Gift : show line 3 in the form 10b5-1 +150,000 150,000 I
2026-06-01 Sale : show line 4 in the form 10b5-1 −12,837 $69.74 $895,252 2,565,489 I
Open-market sales · 12,837 sh · avg $69.74 · $895,252
Loading xslF345X06/ownership.xml…